• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于预测肾透明细胞癌预后的影像组学列线图的开发与验证

Development and Validation of a Radiomic Nomogram for Predicting the Prognosis of Kidney Renal Clear Cell Carcinoma.

作者信息

Gao Ruizhi, Qin Hui, Lin Peng, Ma Chenjun, Li Chengyang, Wen Rong, Huang Jing, Wan Da, Wen Dongyue, Liang Yiqiong, Huang Jiang, Li Xin, Wang Xinrong, Chen Gang, He Yun, Yang Hong

机构信息

Department of Medical Ultrasound, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.

Department of Urology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.

出版信息

Front Oncol. 2021 Jul 6;11:613668. doi: 10.3389/fonc.2021.613668. eCollection 2021.

DOI:10.3389/fonc.2021.613668
PMID:34295804
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8290524/
Abstract

PURPOSE

The present study aims to comprehensively investigate the prognostic value of a radiomic nomogram that integrates contrast-enhanced computed tomography (CECT) radiomic signature and clinicopathological parameters in kidney renal clear cell carcinoma (KIRC).

METHODS

A total of 136 and 78 KIRC patients from the training and validation cohorts were included in the retrospective study. The intraclass correlation coefficient (ICC) was used to assess reproducibility of radiomic feature extraction. Univariate Cox analysis and least absolute shrinkage and selection operator (LASSO) as well as multivariate Cox analysis were utilized to construct radiomic signature and clinical signature in the training cohort. A prognostic nomogram was established containing a radiomic signature and clinicopathological parameters by using a multivariate Cox analysis. The predictive ability of the nomogram [relative operating characteristic curve (ROC), concordance index (C-index), Hosmer-Lemeshow test, and calibration curve] was evaluated in the training cohort and validated in the validation cohort. Patients were split into high- and low-risk groups, and the Kaplan-Meier (KM) method was conducted to identify the forecasting ability of the established models. In addition, genes related with the radiomic risk score were determined by weighted correlation network analysis (WGCNA) and were used to conduct functional analysis.

RESULTS

A total of 2,944 radiomic features were acquired from the tumor volumes of interest (VOIs) of CECT images. The radiomic signature, including ten selected features, and the clinical signature, including three selected clinical variables, showed good performance in the training and validation cohorts [area under the curve (AUC), 0.897 and 0.712 for the radiomic signature; 0.827 and 0.822 for the clinical signature, respectively]. The radiomic prognostic nomogram showed favorable performance and calibration in the training cohort (AUC, 0.896, C-index, 0.846), which was verified in the validation cohort (AUC, 0.768). KM curves indicated that the progression-free interval (PFI) time was dramatically shorter in the high-risk group than in the low-risk group. The functional analysis indicated that radiomic signature was significantly associated with T cell activation.

CONCLUSIONS

The nomogram combined with CECT radiomic and clinicopathological signatures exhibits excellent power in predicting the PFI of KIRC patients, which may aid in clinical management and prognostic evaluation of cancer patients.

摘要

目的

本研究旨在全面调查一种整合增强计算机断层扫描(CECT)影像组学特征与临床病理参数的影像组学列线图在肾透明细胞癌(KIRC)中的预后价值。

方法

本回顾性研究纳入了来自训练队列和验证队列的136例和78例KIRC患者。组内相关系数(ICC)用于评估影像组学特征提取的可重复性。在训练队列中,采用单因素Cox分析、最小绝对收缩和选择算子(LASSO)以及多因素Cox分析来构建影像组学特征和临床特征。通过多因素Cox分析建立了一个包含影像组学特征和临床病理参数的预后列线图。在训练队列中评估列线图的预测能力[相对操作特征曲线(ROC)、一致性指数(C指数)、Hosmer-Lemeshow检验和校准曲线],并在验证队列中进行验证。将患者分为高风险组和低风险组,采用Kaplan-Meier(KM)方法来确定所建立模型的预测能力。此外,通过加权基因共表达网络分析(WGCNA)确定与影像组学风险评分相关的基因,并用于进行功能分析。

结果

从CECT图像的感兴趣肿瘤体积(VOI)中总共获取了2944个影像组学特征。影像组学特征(包括10个选定特征)和临床特征(包括3个选定的临床变量)在训练队列和验证队列中均表现良好[曲线下面积(AUC),影像组学特征分别为0.897和0.712;临床特征分别为0.827和0.822]。影像组学预后列线图在训练队列中表现出良好的性能和校准(AUC,0.896,C指数,0.846),并在验证队列中得到验证(AUC,0.768)。KM曲线表明,高风险组的无进展生存期(PFI)时间明显短于低风险组。功能分析表明,影像组学特征与T细胞活化显著相关。

结论

结合CECT影像组学和临床病理特征的列线图在预测KIRC患者的PFI方面表现出优异的能力,这可能有助于癌症患者的临床管理和预后评估。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3c5/8290524/81e22c6749fc/fonc-11-613668-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3c5/8290524/6f1fc7b9a47c/fonc-11-613668-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3c5/8290524/ee07cbbdad88/fonc-11-613668-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3c5/8290524/fc50ca031e3d/fonc-11-613668-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3c5/8290524/7e5103a0e6bc/fonc-11-613668-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3c5/8290524/e606f95ca42d/fonc-11-613668-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3c5/8290524/84ce2ff1c087/fonc-11-613668-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3c5/8290524/d20d5bc88603/fonc-11-613668-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3c5/8290524/aa183fa79f2e/fonc-11-613668-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3c5/8290524/5f89a7ec72c2/fonc-11-613668-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3c5/8290524/d746a2be3dc2/fonc-11-613668-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3c5/8290524/fdcfda271839/fonc-11-613668-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3c5/8290524/81e22c6749fc/fonc-11-613668-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3c5/8290524/6f1fc7b9a47c/fonc-11-613668-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3c5/8290524/ee07cbbdad88/fonc-11-613668-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3c5/8290524/fc50ca031e3d/fonc-11-613668-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3c5/8290524/7e5103a0e6bc/fonc-11-613668-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3c5/8290524/e606f95ca42d/fonc-11-613668-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3c5/8290524/84ce2ff1c087/fonc-11-613668-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3c5/8290524/d20d5bc88603/fonc-11-613668-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3c5/8290524/aa183fa79f2e/fonc-11-613668-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3c5/8290524/5f89a7ec72c2/fonc-11-613668-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3c5/8290524/d746a2be3dc2/fonc-11-613668-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3c5/8290524/fdcfda271839/fonc-11-613668-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3c5/8290524/81e22c6749fc/fonc-11-613668-g012.jpg

相似文献

1
Development and Validation of a Radiomic Nomogram for Predicting the Prognosis of Kidney Renal Clear Cell Carcinoma.用于预测肾透明细胞癌预后的影像组学列线图的开发与验证
Front Oncol. 2021 Jul 6;11:613668. doi: 10.3389/fonc.2021.613668. eCollection 2021.
2
Radiomic nomogram based on MRI to predict grade of branching type intraductal papillary mucinous neoplasms of the pancreas: a multicenter study.基于 MRI 的放射组学列线图预测胰腺分支型管状乳头状黏液性肿瘤的分级:一项多中心研究。
Cancer Imaging. 2021 Mar 9;21(1):26. doi: 10.1186/s40644-021-00395-6.
3
A prognostic nomogram for T3N0M0 esophageal squamous cell carcinoma patients undergoing radical surgery based on computed tomography radiomics and inflammatory nutritional biomarkers.基于 CT 影像组学和炎症营养生物标志物的 T3N0M0 食管鳞癌根治术后患者的预后列线图
J Appl Clin Med Phys. 2024 Nov;25(11):e14504. doi: 10.1002/acm2.14504. Epub 2024 Sep 6.
4
Preoperative CT Radiomics Predicting the SSIGN Risk Groups in Patients With Clear Cell Renal Cell Carcinoma: Development and Multicenter Validation.术前CT影像组学预测透明细胞肾细胞癌患者的SSIGN风险分组:模型建立与多中心验证
Front Oncol. 2020 Jul 28;10:909. doi: 10.3389/fonc.2020.00909. eCollection 2020.
5
A methylomics-correlated nomogram predicts the recurrence free survival risk of kidney renal clear cell carcinoma.甲基化组学相关列线图预测肾透明细胞癌无复发生存风险。
Math Biosci Eng. 2021 Oct 8;18(6):8559-8576. doi: 10.3934/mbe.2021424.
6
Evaluation of Lymph Node Metastasis in Advanced Gastric Cancer Using Magnetic Resonance Imaging-Based Radiomics.基于磁共振成像的放射组学对进展期胃癌淋巴结转移的评估
Front Oncol. 2019 Nov 22;9:1265. doi: 10.3389/fonc.2019.01265. eCollection 2019.
7
Radiomic signatures based on pretreatment 18F-FDG PET/CT, combined with clinicopathological characteristics, as early prognostic biomarkers among patients with invasive breast cancer.基于治疗前18F-FDG PET/CT的影像组学特征,联合临床病理特征,作为浸润性乳腺癌患者的早期预后生物标志物。
Front Oncol. 2023 Jul 27;13:1210125. doi: 10.3389/fonc.2023.1210125. eCollection 2023.
8
Identification of an m6A-Related lncRNA Signature for Predicting the Prognosis in Patients With Kidney Renal Clear Cell Carcinoma.用于预测肾透明细胞癌患者预后的m6A相关长链非编码RNA特征的鉴定
Front Oncol. 2021 May 26;11:663263. doi: 10.3389/fonc.2021.663263. eCollection 2021.
9
Preoperative computed tomography-guided disease-free survival prediction in gastric cancer: a multicenter radiomics study.术前计算机断层扫描引导的胃癌无病生存预测:一项多中心放射组学研究
Med Phys. 2020 Oct;47(10):4862-4871. doi: 10.1002/mp.14350. Epub 2020 Aug 5.
10
Construction and validation of an autophagy-related long noncoding RNA signature for prognosis prediction in kidney renal clear cell carcinoma patients.构建并验证自噬相关长非编码 RNA 标志物用于预测肾透明细胞癌患者的预后
Cancer Med. 2021 Apr;10(7):2359-2369. doi: 10.1002/cam4.3820. Epub 2021 Mar 2.

引用本文的文献

1
Prognostic Utility of Combining VI-RADS Scores and CYFRA 21-1 Levels in Bladder Cancer: A Retrospective Single-Center Study.联合VI-RADS评分与CYFRA 21-1水平在膀胱癌中的预后价值:一项回顾性单中心研究
Curr Oncol. 2025 Jul 24;32(8):415. doi: 10.3390/curroncol32080415.
2
Radiomics-Based Classification of Clear Cell Renal Cell Carcinoma ISUP Grade: A Machine Learning Approach with SHAP-Enhanced Explainability.基于影像组学的透明细胞肾细胞癌ISUP分级分类:一种具有SHAP增强可解释性的机器学习方法
Diagnostics (Basel). 2025 May 26;15(11):1337. doi: 10.3390/diagnostics15111337.
3
From Images to Genes: Radiogenomics Based on Artificial Intelligence to Achieve Non-Invasive Precision Medicine in Cancer Patients.

本文引用的文献

1
Machine Learning-Based Ultrasomics Improves the Diagnostic Performance in Differentiating Focal Nodular Hyperplasia and Atypical Hepatocellular Carcinoma.基于机器学习的超声组学提高了鉴别局灶性结节性增生和非典型肝细胞癌的诊断性能。
Front Oncol. 2021 Mar 26;11:544979. doi: 10.3389/fonc.2021.544979. eCollection 2021.
2
Systematic Analysis of microRNA Biomarkers for Diagnosis, Prognosis, and Therapy in Patients With Clear Cell Renal Cell Carcinoma.透明细胞肾细胞癌患者诊断、预后及治疗的微小RNA生物标志物的系统分析
Front Oncol. 2020 Dec 4;10:543817. doi: 10.3389/fonc.2020.543817. eCollection 2020.
3
Radiomics and Artificial Intelligence for Renal Mass Characterization.
从图像到基因:基于人工智能的放射基因组学助力癌症患者实现无创精准医疗
Adv Sci (Weinh). 2025 Jan;12(2):e2408069. doi: 10.1002/advs.202408069. Epub 2024 Nov 13.
4
Clinical application of radiomics for the prediction of treatment outcome and survival in patients with renal cell carcinoma: a systematic review.基于影像组学的肾癌患者治疗效果和生存预测的临床应用:一项系统性综述。
World J Urol. 2024 Sep 26;42(1):541. doi: 10.1007/s00345-024-05247-z.
5
Radiomics nomogram based on CT radiomics features and clinical factors for prediction of Ki-67 expression and prognosis in clear cell renal cell carcinoma: a two-center study.基于 CT 影像组学特征和临床因素的列线图预测透明细胞肾细胞癌 Ki-67 表达和预后的研究:一项多中心研究。
Cancer Imaging. 2024 Aug 6;24(1):103. doi: 10.1186/s40644-024-00744-1.
6
Incremental value of radiomics with machine learning to the existing prognostic models for predicting outcome in renal cell carcinoma.基于机器学习的影像组学对预测肾细胞癌预后的现有预后模型的增量价值。
Front Oncol. 2023 Apr 28;13:1036734. doi: 10.3389/fonc.2023.1036734. eCollection 2023.
7
The Impact of Image Acquisition Parameters and ComBat Harmonization on the Predictive Performance of Radiomics: A Renal Cell Carcinoma Model.图像采集参数和ComBat归一化对影像组学预测性能的影响:肾细胞癌模型
Appl Sci (Basel). 2022 Oct;12(19). doi: 10.3390/app12199824. Epub 2022 Sep 29.
8
Effectiveness of Radiomic ZOT Features in the Automated Discrimination of Oncocytoma from Clear Cell Renal Cancer.放射组学ZOT特征在嗜酸性细胞瘤与透明细胞肾癌自动鉴别中的有效性
J Pers Med. 2023 Mar 6;13(3):478. doi: 10.3390/jpm13030478.
9
What Genetics Can Do for Oncological Imaging: A Systematic Review of the Genetic Validation Data Used in Radiomics Studies.遗传学在肿瘤影像学中的作用:放射组学研究中遗传验证数据的系统评价。
Int J Mol Sci. 2022 Jun 10;23(12):6504. doi: 10.3390/ijms23126504.
10
Deep Learning Using CT Images to Grade Clear Cell Renal Cell Carcinoma: Development and Validation of a Prediction Model.使用CT图像的深度学习对透明细胞肾细胞癌进行分级:预测模型的开发与验证
Cancers (Basel). 2022 May 24;14(11):2574. doi: 10.3390/cancers14112574.
用于肾肿物特征描述的放射组学与人工智能
Radiol Clin North Am. 2020 Sep;58(5):995-1008. doi: 10.1016/j.rcl.2020.06.001. Epub 2020 Jul 16.
4
A CT-Based Radiomics Approach for the Differential Diagnosis of Sarcomatoid and Clear Cell Renal Cell Carcinoma.基于 CT 的影像组学方法在梭形细胞和透明细胞肾细胞癌鉴别诊断中的应用。
Biomed Res Int. 2020 Jul 24;2020:7103647. doi: 10.1155/2020/7103647. eCollection 2020.
5
Prediction models for clear cell renal cell carcinoma ISUP/WHO grade: comparison between CT radiomics and conventional contrast-enhanced CT.用于透明细胞肾细胞癌 ISUP/WHO 分级的预测模型:CT 放射组学与常规增强 CT 的比较。
Br J Radiol. 2020 Oct 1;93(1114):20200131. doi: 10.1259/bjr.20200131. Epub 2020 Aug 12.
6
Preoperative Pathological Grading of Hepatocellular Carcinoma Using Ultrasomics of Contrast-Enhanced Ultrasound.超声造影声超组学术前预测肝细胞癌病理分级
Acad Radiol. 2021 Aug;28(8):1094-1101. doi: 10.1016/j.acra.2020.05.033. Epub 2020 Jul 2.
7
A CT-based radiomics signature for evaluating tumor infiltrating Treg cells and outcome prediction of gastric cancer.一种基于CT的影像组学特征用于评估肿瘤浸润性调节性T细胞及预测胃癌预后
Ann Transl Med. 2020 Apr;8(7):469. doi: 10.21037/atm.2020.03.114.
8
Integrative Radiogenomics Approach for Risk Assessment of Post-Operative Metastasis in Pathological T1 Renal Cell Carcinoma: A Pilot Retrospective Cohort Study.整合放射基因组学方法用于评估病理T1期肾细胞癌术后转移风险:一项前瞻性回顾性队列研究
Cancers (Basel). 2020 Apr 2;12(4):866. doi: 10.3390/cancers12040866.
9
Noninvasive Fuhrman grading of clear cell renal cell carcinoma using computed tomography radiomic features and machine learning.使用计算机断层扫描放射组学特征和机器学习对透明细胞肾细胞癌进行无创富尔曼分级。
Radiol Med. 2020 Aug;125(8):754-762. doi: 10.1007/s11547-020-01169-z. Epub 2020 Mar 19.
10
Identifying BAP1 Mutations in Clear-Cell Renal Cell Carcinoma by CT Radiomics: Preliminary Findings.通过CT影像组学识别透明细胞肾细胞癌中的BAP1突变:初步研究结果
Front Oncol. 2020 Feb 28;10:279. doi: 10.3389/fonc.2020.00279. eCollection 2020.